May 2nd, 2014
A New Tool to Discuss Primary Prevention with a Statin with Patients: Life Expectancy Gain
Darrel P Francis, MD FRCP
Darrel Francis describes how you can use life expectancy gain as a way to communicate with patients the pros and cons of taking a statin.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?